NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE14268.201767.45 (+14.14 %)
PREV CLOSE ( ) 12500.75
OPEN PRICE ( ) 12749.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11024
TODAY'S LOW / HIGH ( )12393.10 14500.35
52 WK LOW / HIGH ( )3612.05 13600
NSE14247.651748.5 (+13.99 %)
PREV CLOSE( ) 12499.15
OPEN PRICE ( ) 12500.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 14247.65 (115)
VOLUME 157171
TODAY'S LOW / HIGH( ) 12343.05 14489.90
52 WK LOW / HIGH ( )3611.1 13630
( in Million)
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax4014.372157.46821.631053.34529.23
Adjustment620.76779.28663.04400.85582.76
Changes In working Capital-907.32-128.34-675.85492.17-491.73
Cash Flow after changes in Working Capital3727.802808.40808.821946.35620.25
Cash Flow from Operating Activities2611.772372.12603.891893.62573.41
Cash Flow from Investing Activities-1496.87-614.99-955.16-844.24-486.80
Cash Flow from Financing Activities-692.82-1357.96377.22-1136.60-54.80
Net Cash Inflow / Outflow422.08399.1825.94-87.2231.81
Opening Cash & Cash Equivalents454.1650.9124.36112.0479.38
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations-0.494.070.62-0.460.85
Closing Cash & Cash Equivalent875.75454.1650.9124.36112.04

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.